Thymoquinone and chemoresistance in non-small cell lung cancer: Preclinical promise or therapeutic potential?

Maryam Alsadat  Baniaghil; Seyedeh Hatameh  Asadinejad Tahergourabi; Niloofar  Keikhaei

doi:10.61882/jcbior.6.1.285

Authors

Maryam Alsadat Baniaghil Firouzgar Hospital, Department of Internal Medicine, School Of Medicine, Iran University of Medical Sciences, Tehran, Iran
Seyedeh Hatameh Asadinejad Tahergourabi Firouzgar Hospital, Department of Internal Medicine, School Of Medicine, Iran University of Medical Sciences, Tehran, Iran https://orcid.org/0009-0008-6790-8685
Niloofar Keikhaei Sayad Shirazi Hospital, Department of Internal Medicine, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran

DOI:

https://doi.org/10.61882/jcbior.6.1.285

Keywords:

Thymoquinone, Nigella sativa, Black cumin, Lung cancer, Chemoresistance

Abstract

No Abstract.

References

1. Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc. 2008;83(5):584-94.

DOI: 10.4065/83.5.584 PMID: 18452692

2. Alaufi OM, Noorwali A, Zahran F, Al-Abd AM, Al-Attas S. Cytotoxicity of thymoquinone alone or in combination with cisplatin (CDDP) against oral squamous cell carcinoma in vitro. Sci Rep. 2017;7(1):13131. DOI: 10.1038/s41598-017-13357-5 PMID: 29030590

3. Durga BB, Ramachandran V, Senthil B, Soloman VG, Elshikh MS, Almutairi SM, et al. Unleashing of cytotoxic effects of thymoquinone-bovine serum albumin nanoparticles on A549 lung cancer cells. Open Life Sci. 2024;19(1):20221000.

DOI: 10.1515/biol-2022-1000 PMID: 39655191

4. Yang J, Kuang XR, Lv PT, Yan XX. Thymoquinone inhibits proliferation and invasion of human nonsmall-cell lung cancer cells via ERK pathway. Tumour Biol. 2015;36(1):259-69.

DOI: 10.1007/s13277-014-2628-z PMID: 25238880

5. Gurbilek M, Deniz CD, Eroglu Gunes C, Kurar E, Reisli I, Kursunel MA, et al. Anticancer activity of thymoquinone in non-small cell lung cancer and possible involvement of PPAR-γ pathway. Int J Radiat Biol. 2025;101(4):370-381.

DOI: 10.1080/09553002.2025.2449953 PMID: 39946226

6. Jafri SH, Glass J, Shi R, Zhang S, Prince M, Kleiner-Hancock H. Thymoquinone and cisplatin as a therapeutic combination in lung cancer: In vitro and in vivo. J Exp Clin Cancer Res. 2010;29(1):87. DOI: 10.1186/1756-9966-29-87

PMID: 20594324

7. Gomathinayagam R, Ha JH, Jayaraman M, Song YS, Isidoro C, Dhanasekaran DN. Chemopreventive and Anticancer Effects of Thymoquinone: Cellular and Molecular Targets. J Cancer Prev. 2020;25(3):136-151. DOI: 10.15430/JCP.2020.25.3.136

PMID: 33033708

8. Zhang Y, Liu X, Dang W, Liu L. Thymoquinone inhibits lung cancer stem cell properties via triggering YAP degradation. Carcinogenesis. 2023;44(5):426-435.

DOI: 10.1093/carcin/bgad026 PMID: 37105709

9. Ansar FH, Latifah SY, Wan Kamal WHB, Khong KC, Ng Y, Foong JN, et al. Pharmacokinetics and Biodistribution of Thymoquinone-loaded Nanostructured Lipid Carrier After Oral and Intravenous Administration into Rats. Int J Nanomedicine. 2020;15:7703-7717. DOI: 10.2147/IJN.S262395

PMID: 33116496